MR
Manikanth Reddy Yarala
About Manikanth Reddy Yarala
Data last updated:
Manikanth Reddy Yarala is a Director at Energon Labs Private Limited (since 2025), Director at Rx-Infinity Therapeutics Private Limited (since 2023) and Designated Partner at Tervis Therapeutics Llp (since 2021). The companies operate in Pharma, Paper and Research & Development. The 2 current companies with reported revenue have a combined latest revenue of ₹42.61 Cr; the largest is Energon Labs Private Limited at ₹42.42 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Energon Labs Private Limited U73200TG2018PTC127126 | Director | 22 Jan 2025 | 2018 | ₹42.42 Cr (FY 2024) | Active |
 Rx-Infinity Therapeutics Private Limited U21001TS2023PTC173621 | Director | 31 May 2023 | 2023 | ₹19.5 Lakh (FY 2025) | Active |
| Tervis Therapeutics Llp AAX-2612 | Designated Partner | 03 Jun 2021 | 2021 | Active |
Board colleagues of Manikanth Reddy Yarala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Surekha Maddula | 08258532 | Energon Labs Private Limited | Director |
| Umamaheswar Siripurapu | 09379719 | Energon Labs Private Limited | Director |
| Veeranna Singuluri | 06824501 | Energon Labs Private Limited | Director |
| Ramadevi Amaram | 09106867 | Rx-Infinity Therapeutics Private Limited | Director |
| Sandhya Rani Bandla | 09192792 | Tervis Therapeutics Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manikanth Reddy Yarala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manikanth Reddy Yarala
Manikanth Reddy Yarala currently holds 3 directorships: Energon Labs Private Limited (Director, since 22 Jan 2025, revenue ₹42.42 Cr (FY 2024)); Rx-Infinity Therapeutics Private Limited (Director, since 31 May 2023, revenue ₹19.5 Lakh (FY 2025)); Tervis Therapeutics Llp (Designated Partner, since 03 Jun 2021).
Manikanth Reddy Yarala was first appointed on 03 Jun 2021 as Designated Partner at Tervis Therapeutics Llp. The most recent appointment on record is 22 Jan 2025 at Energon Labs Private Limited.
The 2 current companies of Manikanth Reddy Yarala that report revenue have a combined latest revenue of ₹42.61 Cr: Energon Labs Private Limited ₹42.42 Cr (FY 2024); Rx-Infinity Therapeutics Private Limited ₹19.5 Lakh (FY 2025).
The current boards of Manikanth Reddy Yarala's companies include Surekha Maddula (Energon Labs Private Limited), Umamaheswar Siripurapu (Energon Labs Private Limited), Veeranna Singuluri (Energon Labs Private Limited), Ramadevi Amaram (Rx-Infinity Therapeutics Private Limited), Sandhya Rani Bandla (Tervis Therapeutics Llp).